Temporally Optimized Patterned Stimulation (TOPS®) Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease
Launched by DEEP BRAIN INNOVATIONS LLC · May 14, 2020
Trial Information
Current as of August 02, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Key Inclusion Criteria:
- • Diagnosed with Parkinson's disease
- • Implanted with unilateral or bilateral subthalamic DBS System to treat Parkinson's disease at least 6 months prior to the study date
- • Responds to DBS by having demonstrated a minimum improvement in motor score
- Key Exclusion Criteria:
- • Score of \<24 on the Mini Mental Status Exam
- • Abuses drugs or alcohol
- • Pregnant
- • History of significant cardiovascular, pulmonary, musculoskeletal, metabolic, or other neurological disorders (i.e. epilepsy, stroke)
- • Prisoners, employees that report to investigators
About Deep Brain Innovations Llc
Deep Brain Innovations LLC is a pioneering clinical trial sponsor dedicated to advancing neurotechnology solutions for neurological disorders. By harnessing cutting-edge research and innovative approaches, the company focuses on developing and evaluating therapeutic interventions that target deep brain structures to improve patient outcomes. With a commitment to collaboration and excellence, Deep Brain Innovations LLC aims to bridge the gap between scientific discovery and clinical application, ultimately enhancing the quality of life for individuals affected by complex neurological conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Durham, North Carolina, United States
Gainesville, Florida, United States
Durham, North Carolina, United States
Gainesville, Florida, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials